A serious women standing in front of two medical professionals and her family and dog. In the background of the image is an x-ray image of lungs.

LATE STAGE IS NOT TOO LATE TO FACE LUNG CANCER HEAD ON

Biomarker research continues to pave the way for personalized approaches to managing late-stage non-small cell lung cancer (NSCLC). Understanding your current biomarker status may help you and your doctor make more informed decisions about your cancer care.

To get the most up-to-date information about your NSCLC, talk to your doctor about comprehensive biomarker retesting.

Late stage is considered Stage IV. In this stage, cancer has spread beyond the lung.

Get the Biomarker CONVERSATION Guide

STAY INFORMED

AND EMPOWER YOURSELF WITH KNOWLEDGE

KNOW WHY BIOMARKER

TESTING MATTERS

See Why

Advancements in late-stage

NSCLC

Find Out

Discover Quick Facts

About Biomarkers

Learn More